Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2VNQtNY
via IFTTT